or Try an Advanced Search...

    Technical Analysis for ALPN - Alpine Immune Sciences, Inc.

    Grade Last Price % Change Price Change
    F 7.75 2.65% 0.20
    ALPN closed up 2.65 percent on Friday, June 28, 2024, on 0 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Extremely Strong Down Down Flat
    Historical ALPN trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish -83.52%
    MACD Bullish Signal Line Cross Bullish -83.52%
    New 52 Week Closing High Bullish -83.52%
    Expansion Breakout Bullish Swing Setup -83.52%
    Pocket Pivot Bullish Swing Setup -83.52%
    Reversal New Highs Setup Bullish Swing Setup -83.52%
    Volume Surge Other -83.52%
    Wide Range Bar Range Expansion -83.52%
    New 52 Week High Strength -83.52%
    20 DMA Support Bullish -80.10%
    Older End-of-Day Signals for ALPN ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ALPN Chart by TradingView
    Basic chart:

    Profile

    Alpine Immune Sciences, Inc., a development-stage specialty pharmaceutical company, engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. It is developing ALPN-101, an ICOS/CD28 antagonist program for the treatment of inflammatory diseases. The company is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases

    Is ALPN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
    May 10 Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires
    May 9 Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.12, revenue of $7.03M beats by $3.51M
    May 9 Alpine Immune Sciences Reports First Quarter 2024 Financial Results
    May 7 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
    May 7 Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
    May 7 Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
    May 7 Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
    May 2 Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
    Apr 18 Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
    See more ALPN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 65.0
    52 Week Low 7.5
    Average Volume 2,250,348
    200-Day Moving Average 25.80
    50-Day Moving Average 42.23
    20-Day Moving Average 16.39
    10-Day Moving Average 7.77
    Average True Range 1.62
    RSI (14) 9.91
    ADX 77.85
    +DI 8.03
    -DI 80.23
    Chandelier Exit (Long, 3 ATRs) 60.14
    Chandelier Exit (Short, 3 ATRs) 12.36
    Upper Bollinger Bands 57.20
    Lower Bollinger Band -24.43
    Percent B (%b) 0.39
    BandWidth 498.23
    MACD Line -11.19
    MACD Signal Line -11.95
    MACD Histogram 0.7637
    Fundamentals Value
    Market Cap 507.9 Million
    Num Shares 65.5 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -6.01
    Price-to-Sales 64.64
    Price-to-Book 11.77
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.75
    Resistance 3 (R3) 7.75 7.75 7.75
    Resistance 2 (R2) 7.75 7.75 7.75 7.75
    Resistance 1 (R1) 7.75 7.75 7.75 7.75 7.75
    Pivot Point 7.75 7.75 7.75 7.75 7.75
    Support 1 (S1) 7.75 7.75 7.75 7.75 7.75
    Support 2 (S2) 7.75 7.75 7.75 7.75
    Support 3 (S3) 7.75 7.75 7.75
    Support 4 (S4) 7.75